All In MedTech

Device Trial Radar · NCT06699160

Refobacin Revision-3 Bone Cement Post-Market Study

Post Market Clinical Follow-up Study on the Refobacin Revision-3 Bone Cement and Its Instrumentation

Last checked: Nov 20, 2026Latest source record: Nov 25, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Withdrawn

Status

Withdrawn

Enrollment

0

Actual

Start

Aug 2025

Primary completion

Dec 2030

Study completion Dec 2030

Sponsor

Lead sponsor
Zimmer BiometPublic (ZBH)
Sponsor type
Industry
First posted
Nov 21, 2024

More device trials from this sponsor

Design

Study type
Observational
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this post-market study is to confirm the safety, performance and clinical benefits of the Refobacin Revision-3 Bone Cement when used in knee or hip revision surgeries. This will be done by collecting information on: * removal of any metal components of the hip or knee implants used in combination with the cement * frequency and incidence of adverse events * overall pain and functional performance, subject quality of life, and radiographic parameters

Conditions

  • Revision Arthroplasty

Interventions

  • Revision arthroplastyDevice

    Hip or knee revision surgery resulting from aseptic loosening of the prosthesis and/or infection of the prosthesis by gentamicin and/or clindamycin sensitive strains.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. SurvivorshipTime frame: 3, 5 and 10 years post-operatively

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Diakonessenhuis UMC Utrecht

    Utrecht, Netherlands

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.